EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping ReviewOpen Access · CC BY 4.0

Metabolomic Insights into Attention Deficit Hyperactivity Disorder: A Scoping Review

Maria Jose Muñoz-Zabaleta iD, Nicolás Garzón Rodríguez iD, Luis Eduardo Díaz-Barrera iD, Maria Fernanda Quiroz-Padilla iD

Metabolites · 16.02.2025 · 15 (2) · 133

DOI: 10.3390/metabo15020133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 16.02.2025. Verfasst von Maria Jose Muñoz-Zabaleta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Bases Biológicas del Comportamiento, Facultad de Psicología y Ciencias del Comportamiento, Universidad de La Sabana, Chía 250001, Colo…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de La Sabana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background /Objectives Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental condition, and symptoms persist into adulthood. Its etiology, though recognized as multifactorial, is still under discussion. Metabolomics helps us to identify pathways associated with functional and structural changes that may be related to symptomatology. This study aimed to characterize potentially altered metabolic pathways and associated biochemical reactions in ADHD.

Methods

A scoping review of experimental research was conducted using PubMed, Web of Science, and Scopus using PRISMA ScR. Fifty-five studies were eligible for data extraction, of which fifteen met the criteria for inclusion in the review. Subsequently, the identified metabolites were analyzed in the context of the literature to recognize possible discordant pathways in the disorder.

Results

Two groups of relevant neuromodulators of ADHD were found: precursors of monoamines and polyunsaturated fatty acids. The literature was reviewed to discover potential implicated pathways and new metabolites of interest.

Conclusions

The study of ADHD biomarkers should focus on measuring precursor, intermediate, and final metabolites of polyunsaturated fatty acids and monoamines in panels or through untargeted analysis to improve the understanding of the pathology and individualization of treatments.

Schlagwörter

Stichwörter der Autor:innen

ADHDbiomarkerslipidomicmetabolitesmetabolomics

Autor:innen und Institutionen

  • Laboratorio de Bases Biológicas del Comportamiento, Facultad de Psicología y Ciencias del Comportamiento, Universidad de La Sabana, Chía 250001, Colombia.
  • Doctorado en Psicología, Facultad de Psicología y Ciencias del Comportamiento, Universidad de La Sabana, Chía 250001, Colombia.
  • Doctorado en Biociencias, Facultad de Ingeniería, Universidad de La Sabana, Chía 250001, Colombia.
  • Bioprospecting Research Group, Facultad de Ingeniería, Universidad de La Sabana, Chía 250001, Colombia.

ORCID-Profile: Maria Jose Muñoz-Zabaleta, Nicolás Garzón Rodríguez, Luis Eduardo Díaz-Barrera, Maria Fernanda Quiroz-Padilla

Förderung

  • Universidad de La Sabana

Zitieren

APA

Muñoz-Zabaleta, M. J., Garzón Rodríguez, N., Díaz-Barrera, L. E., & Quiroz-Padilla, M. F. (2025). Metabolomic Insights into Attention Deficit Hyperactivity Disorder: A Scoping Review. Metabolites, 15(2), 133. https://doi.org/10.3390/metabo15020133

Vancouver

Muñoz-Zabaleta MJ, Garzón Rodríguez N, Díaz-Barrera LE, Quiroz-Padilla MF. Metabolomic Insights into Attention Deficit Hyperactivity Disorder: A Scoping Review. Metabolites. 2025;15(2):133. doi:10.3390/metabo15020133

BibTeX
@article{MuozZabaleta2025,
  author = {Muñoz-Zabaleta, Maria Jose and Garzón Rodríguez, Nicolás and Díaz-Barrera, Luis Eduardo and Quiroz-Padilla, Maria Fernanda},
  title = {Metabolomic Insights into Attention Deficit Hyperactivity Disorder: A Scoping Review},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {133},
  doi = {10.3390/metabo15020133}
}
Kostenlos starten →